ClinicalTrialsFinder

Refractory or Relapsed Diffuse Large B Cell Lymphoma Clinical Trials in Hanzhou, Zhejiang

1 recruitingHanzhou, Zhejiang, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

A Study of Zanubrutinib in Combination With Polatuzumab Vedotin, Bendamustine and Rituximab in the Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma

Refractory or Relapsed Diffuse Large B Cell Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University36 enrolled1 locationNCT06554600